iOrganBio
PrivateLast Round
Seed
Oct 29, 2025
Total Funding Raised
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
iOrganBio is a biotechnology company that provides an AI-powered platform called CellForge for the intelligent manufacturing of cells and organoids to accelerate disease modeling, regenerative medicine, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOrganBio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
iOrganBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2025 |
iOrganBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Terasaki Institute for Biomedical Innovation | Seed |
| Alix Ventures | Seed |
| 2ndF | Seed |
| First Star Ventures | Seed |
| IndieBio | Seed |
| Cape Fear BioCapital | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 33% QoQ from 12 to 16 employees.
- Jan 28, 2026
Emerged from stealth with the launch of its CellForge platform.
iOrganBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iOrganBio's valuation, stock price, and market status.